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SEIRportant role in the epidemiology of H5N1 avian inﬂuenza. Although it is known
that vaccines that have a high homology with the challenge virus are able to prevent infection in ducks, little
is yet known about the ability of genetically more distant vaccines in preventing infection, disease, and
transmission. Here we study the effect of a widely used H5N2 vaccine (A/Chicken/Mexico/232/94/CPA) on the
transmission of H5N1 virus (A/Chicken/China/1204/04) in ducks. The quantitative analyses show that despite
the low level of homology between the virus and vaccine strain transmission was signiﬁcantly reduced two
weeks after a single or double vaccination. Mortality and disease rates were reduced markedly already one
week after a single vaccination.
© 2008 Elsevier Inc. All rights reserved.Introduction
Wild aquatic birds are the natural host species for avian inﬂuenza
(Webster et al., 1992; Alexander, 2000). Most highly pathogenic avian
inﬂuenza (HPAI) viruses replicate but do not cause disease symptoms
in ducks (Alexander et al., 1978, 1986; Westbury et al., 1979; Wood et
al., 1985,1995). In accordancewith this ﬁnding, early Asian HPAI H5N1
viruses were non-pathogenic to ducks. However, since 2002 several
H5N1 strains emerged that induce severe disease and mortality, while
other H5N1 strains still cause asymptomatic infections (Sturm-
Ramirez et al., 2004, 2005; Hulse-Post et al., 2005; Kishida et al.,
2005; Tian et al., 2005; Webster et al., 2006b; Beato et al., 2007;
Middleton et al., 2007). Most HPAI viruses can be transmitted from
infected to uninfected ducks, as has been shown in experimental
studies (Alexander et al., 1978, 1986; Westbury et al., 1979; Chen et al.,
2004; Sturm-Ramirez et al., 2004, 2005; Beato et al., 2007; Pantin-
Jackwood et al., 2007). In the group of Asian H5N1 viruses there does
not seem to be a clear correlation between the pathogenicity and the
ability to spread from duck to duck. In fact, transmission is observed in
strains that cause subclinical infections as well as in strains that cause
severe disease and mortality (Sturm-Ramirez et al., 2004, 2005;er Goot).
l rights reserved.Hulse-Post et al., 2005; Beato et al., 2007; Pantin-Jackwood et al.,
2007).
Domestic ducks play an important role in the epidemiology of HPAI
H5N1 viruses. It has been shown that free-ranging ducks act as a
reservoir of H5N1 avian inﬂuenza viruses (Songserm et al., 2006), and
are a risk factor for the presence of H5N1 virus infections of domestic
poultry (Gilbert et al., 2006, 2008). Since not all H5N1 infections are
symptomatic, the chance that infections in adult ducks are not
detected is substantial. This was illustrated by Kwon et al. (2005), who
showed that an H5N1 infection in adult breeder ducks was only
detected after the 9 day old offspring showed signs of infection.
Vaccination is a potentially attractive tool for the prevention and
control of avian inﬂuenza outbreaks. At present, vaccination against
HPAI H5N1 is practiced in several countries e.g. Indonesia, People's
Republic of China and Vietnam (OIE, 2008b). Vaccines based on
different seed viruses are used, with different antigenic homology
with the circulating ﬁeld strains. In chickens it has been shown that
the homology between the hemagglutinin of the vaccine strain and
the challenge strain is an important factor in the reduction of virus
shedding (Swayne et al., 1999, 2000a).
Experimental studies investigating the effect of vaccination in ducks
show that virus excretion is signiﬁcantly reduced after vaccination
(Tian et al., 2005;Webster et al., 2006a; Beato et al., 2007;Middleton et
al., 2007). In fact, in most studies no virus could be isolated from the
Table 1
Transmission of H5N1 in unvaccinated ducks
Pekin ducks were inoculated with A/Chicken/China/1204/04 H5N1 virus.
Two duplicate experiments were performed.
aDay after challenge; I, inoculated bird; S, contact bird; nd, not determined; †, duck died;
x/y, results of the virus isolation in ECE's of the tracheal swab (x) and the cloacal swab
(y); grey box, trachea and/or cloacal swab was positive in the virus isolation; a,
conjunctivitis; b, bird died; c, depressed; –, no symptoms were observed.
Table 3
Transmission of H5N1 in ducks two weeks after a single vaccination
Pekin ducks were inoculated with A/Chicken/China/1204/04 H5N1 virus, two weeks
after a single vaccination with an inactivated H5N2 vaccine (A/Chicken/Mexico/232/94/
CPA). Two duplicate experiments were performed.
aDay after challenge; I, inoculated bird; S, contact bird; nd, not determined; x/y, results
of the virus isolation in ECE's of the tracheal swab (x) and the cloacal swab (y); grey box,
trachea and/or cloacal swab was positive in the virus isolation; a, conjunctivitis; d,
swollen oropharynx; –, no symptoms were observed.
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homology between vaccine and virus strains is high, and that not all
currently used vaccines have this high homology with the recent Asian
H5N1 viruses. For this reason we are interested in the effectiveness of
vaccines that are currently used and that have a larger genetic and
antigenic distance from the Asian H5N1 viruses.
In this paper we report results of transmission experiments that
were carried out to quantify the effectiveness of vaccination with a
widely used H5N2 vaccine (A/Chicken/Mexico/232/94/CPA) in redu-Table 2
Transmission of H5N1 in ducks one week after a single vaccination
Pekin ducks were inoculated with A/Chicken/China/1204/04 H5N1 virus, one week after
a single vaccination with an inactivated H5N2 vaccine (A/Chicken/Mexico/232/94/CPA).
Two duplicate experiments were performed.
aDay after challenge; I, inoculated bird; S, contact bird; nd, not determined; x/y, results
of the virus isolation in ECE's of the tracheal swab (x) and the cloacal swab (y); grey box,
trachea and/or cloacal swab was positive in the virus isolation; a, conjunctivitis; –, no
symptoms were observed.cing disease and transmission of H5N1 virus (A/Chicken/China/1204/
04) in Pekin ducks. In a transmission experiment a number of infected
ducks is housed together with a number of uninfected ducks, and the
infection chain is monitored on a regular basis. In our experiments
disease symptoms and excretion of virus were monitored daily, while
the antibody response was determined weekly. The aim of transmis-
sion experiments is to obtain estimates of the basic reproduction ratio
(R), which is deﬁned as the number of secondary infections that wouldTable 4
Transmission of H5N1 in ducks two weeks after a double vaccination
Pekin ducks were inoculated with A/Chicken/China/1204/04 H5N1 virus, two weeks
after a double vaccinationwith an inactivated H5N2 vaccine (A/Chicken/Mexico/232/94/
CPA). Two duplicate experiments were performed.
aDay after challenge; I, inoculated bird; S, contact bird; nd, not determined; −, swabwas
negative in the RRT-PCR; x/y, results of the virus isolation in ECE's of the tracheal swab
(x) and the cloacal swab (y); grey box, trachea and/or cloacal swab was positive in the
virus isolation; a, conjunctivitis; –′, no symptoms were observed.
Table 5
Overview of the statistical analysis of the transmission experiments
Treatment
group
Final
size
R
(ﬁnal size)
(95% CI)
H0:
R≥1
H0:
Rv=Rc
Infectious
period
(day)
(95% CI)
Transmission
rate parameter
(day−1)
(95% CI)
R
(GLM)
Unvaccinated 5,5 N1.5 ns 4.3
(3.8–4.8)
4.7
(2.3–9.4)
20
Single
vaccination
(challenge:
1 week)
5,5 N1.5 ns ns 3.4
(2.9–3.9)
2.7
(0.87–8.6)
9.2
Single
vaccination
(challenge:
2 weeks)
1,2 0.6
(0.1–2.2)
ns 0.01 3.3
(1.9–4.8)
0.23
(0.09–0.55)
0.76
Double
vaccination
(challenge:
2 weeks)
1,0 0.2
(0.005–1.5)
0.08 0.002 5 (n=1) na na
CI, conﬁdence interval; Rv, reproduction ratio amongst vaccinated ducks; Rc,
reproduction ratio amongst unvaccinated ducks; GLM, generalized linear model; ns,
not signiﬁcant; na, not applicable.
Fig. 1. Ct values of the RRT-PCR of the tracheal swabs of the inoculated ducks. The mean
Ct values of the groups are given.
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susceptible individuals. If R exceeds 1, an infected animal infects on
average more than one susceptible animal, and a chain reaction of
infections may occur. If R is smaller than 1, a prolonged chain reaction
of infections is not possible, and an epidemic cannot occur.
We show that a vaccine that is genetically and antigenically distant
from the HPAI H5N1 virus protects the ducks against severe illness and
mortality and signiﬁcantly reduces the transmission of HPAI H5N1 in
Pekin ducks.
Results
Clinical symptoms
In the unvaccinated groups several birds showed clinical symp-
toms (Table 1). Two inoculated ducks died, and eight other birds
showed depression and/or conjunctivitis. In all vaccinated groups
there was a marked reduction in the number of birds that showed
symptoms. In the groups that were challenged one week after a single
vaccination only two ducks showed conjunctivitis (Table 2). In the
groups that were challenged two weeks after a single vaccination
three ducks showed symptoms: one duck showed conjunctivitis, one
duck had a swollen oropharynx (possibly due to the swabbing), and
one duck showed conjunctivitis and a swollen oropharynx (Table 3). In
the groups that received a double vaccination two ducks showed
conjunctivitis (Table 4).
Effect of vaccination on virus excretion and transmission
In the unvaccinated groups virus was isolated from all inoculated
and all contact ducks (Table 1). The reproduction ratio based on the
ﬁnal size method is RN1.5 with 95% conﬁdence. The transmission rate
parameter calculated using the Generalized Linear Model (GLM) is 4.7
(day−1) (95% CI: 2.3–9.4), and the infectious period is 4.3 days (95% CI:
3.8–4.8) (Table 5).
In the groups that were challenged one week after a single
vaccination virus was also isolated from all inoculated and all contact
ducks (Table 2). Again, the estimate of the reproduction ratio based on
the ﬁnal size method is RN1.5 with 95% conﬁdence. The transmission
rate parameter calculated using the GLM is 2.7 (day−1) (95% CI: 0.87–
8.6), and the infectious period is 3.4 days (95% CI: 2.9–3.9) (Table 5).
In the groups that were challenged two weeks after a single
vaccination virus was isolated from 9 of the 10 inoculated ducks andfrom 3 contact ducks (Table 3). The estimate of the reproduction ratio
R based on the ﬁnal size method is 0.6 (95% CI: 0.1–2.2). The
transmission rate parameter calculated using the GLM is 0.23 (day−1)
(95% CI: 0.09–0.55), and the infectious period is 3.3 days (95% CI: 1.9–
4.8) (Table 5). There is a signiﬁcant difference (p=0.01) between the
reproduction ratios R of the unvaccinated groups and the groups that
were challenged two weeks after a single vaccination.
In the groups that were challenged two weeks after a double
vaccination virus was isolated from 4 of the 9 inoculated ducks and
from one contact duck (Table 4). In one group one duck died before the
start of the experiment, therefore 4 instead of 5 ducks were
inoculated. The estimate of the reproduction ratio based on the ﬁnal
size method is 0.2 (95% CI: 0.005–1.5) (Table 5). The GLM could not be
applied because one contact duck became positive before inoculated
ducks became positive in the virus isolation. Here we also see that
there is a signiﬁcant difference (p=0.002) between the reproduction
ratios R of the groups that received a double vaccination and the
unvaccinated groups (Table 5).
The results of the RRT-PCR are shown in Fig. 1, and in
Supplementary tables of the supplementary data. The mean cycle
threshold (Ct) values of the tracheal swabs of the inoculated ducks of
each group are given, and it shows that vaccination reduces virus
excretion of the ducks already at one week after a single vaccination
(Fig. 1). Logistic regression was applied to the results of the virus
isolation (positive or negative) and the RRT-PCR (Ct value) of the
tracheal swabs of the experiments with the unvaccinated ducks and
the ducks that received a single vaccination (n=617). The estimates for
the intercept (a) and slope (b) parameters are: a=19.34 (SE:2.17), b=
−27.87 (SE:3.14). The analyses show that when the Ct value of the
swab is ≥36.2 the probability of a positive result in the virus isolation
is smaller than 5%, and this can be used as a cut-off value for the RRT-
PCR. When the result of the RRT-PCR is negative, the probability of a
positive result in the virus isolation is 0.0002. This implies that the
RRT-PCR can be used as a pre-screening, and we decided that only
swabs with a positive RRT-PCR result from the experiment with a
double vaccination were inoculated in ECEs.
Serology of the ducks after vaccination
The hemagglutination inhibition (HI) assay was performed with
the challenge virus (H5N1) or the vaccine virus (H5N2) as antigen. In
the groups that were challenged one week after a single vaccination
only 2/20 ducks had ameasurable HI titer with the H5N1 antigen (log2
titers: 1.0 and 1.7) at the moment of challenge (Fig. 2). When the HI
test was performed with the H5N2 antigen 11/20 ducks had a
measurable titerwith a log2 geometricmean titer (GMT) of 1.5 (95% CI:
0.8–2.1) (Fig. 2). In the groups that were challenged two weeks after a
Fig. 2. Hemagglutination inhibition titers of the ducks prior to challenge. The HI test is performed with the challenge strain (H5N1) or the vaccine strain (H5N2). Each box shows the
median value of the HI titers (black line), the interquartile range (upper and lower boundaries of the box), and the range of the HI titers (whiskers). ○, outlier, deﬁned as cases with
values between 1.5 and 3 box lengths from the upper or lower edge of the box; ⁎, extreme value, deﬁned as cases with valuesmore than 3 box lengths from the upper or lower edge of
the box.
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H5N1 antigen at the moment of challenge. When the HI test was
performed with the H5N2 antigen 12/20 ducks had a measurable HI
titer, with a log2 GMTof 2.5 (95% CI:1.4–3.6) (Fig. 2). In the groups that
received a double vaccination 17/19 ducks had a measurable HI titer
with the H5N1 antigen with a log2 GMT of 3.1 (95% CI: 2.1–4.1) and
18/19 ducks had a measurable HI titer with the H5N2 antigen with a
log2 GMT of 6.6 (95% CI: 5.5–7.7) at the moment of challenge (Fig. 2).
Discussion
The effect of the protein homology of the HA1 of the vaccine and
challenge strain on virus shedding after challenge has been studied
systematically in chickens (Swayne et al., 1999, 2000a,b; Lee et al.,
2004). When the protein homology of the HA1 varied from 96.8 to
100% no positive correlationwas found between the sequence identity
of the HA1 from the vaccine strain and challenge virus, and the ability
to reduce the quantity of challenge virus shed from the cloaca or
oropharynx (Swayne et al., 1999). When a fowl pox vectored vaccine
containing the hemagglutinin (HA) of H5 and a variety of challenge
strains was used with a HA1 protein homology varying from 87.3 to
100% there was a signiﬁcant positive correlation in hemagglutinin
sequence similarity between challenge viruses and vaccine, and the
ability to reduce titers of challenge virus isolated from the oropharynx
(Swayne et al., 2000a). In a study where the percentage of amino acid
similarities of the HA1 ranged from84.6 to 99.7% it was also found that
the level of virus shedding in the trachea was correlated with the
antigenic differences of vaccine and challenge strains (Lee et al., 2004).
Transmission in chickens was completely stopped after a single
vaccination with vaccine strains that had a protein homology of the
HA1 of 92 and 98% with the challenge strain (Van der Goot et al.,
2005).
Vaccination against HPAI virus in ducks has been studied less
systematically. Previous studies in ducks generally used vaccines that
had a high homology with the challenge virus. In most experiments
the hemagglutinin of the vaccine and challenge strains both belonged
to the Eurasian H5N1 subtype, and these vaccines were able to
completely prevent virus excretion (Tian et al., 2005; Webster et al.,
2006a; Middleton et al., 2007). Two studies used viruses and vaccines
that were genetically more distant (Beato et al., 2007; Middleton et al.,
2007). Middleton et al. used a vaccine with an H5 virus (A/Chicken/
Italy/22A/98 H5N9) with a protein homology of the HA1 of ∼89% withthe H5N1 challenge virus, and did ﬁnd some virus shedding. Beato
et al. used a vaccine based on the A/Duck/Potsdam/1402/86 H5N2
virus with a protein homology of the HA1 of 89% with the H5N1
challenge strain and did not isolate any virus. When the effect of
vaccination on transmission was studied, no transmission from
inoculated to contact ducks was detected (Webster et al., 2006b;
Beato et al., 2007).
In these previous studies vaccines that had a high degree of
homology (89–100%)with the HA1 of the challenge strainwere able to
completely protect ducks against morbidity and mortality, virus
excretion and transmission. However, not all currently used vaccines
have such a high degree of homology with the circulating H5N1 ﬁeld
viruses. Reasons to choose a genetically more distant vaccine may be
the availability of vaccines or the choice for a vaccine with a different
neuraminidase to be able to adopt a DIVA (Differentiating Infected
from Vaccinated Animals) strategy (Capua et al., 2002). In ducks little
is known about the effectiveness of genetically more distant vaccines
in preventing infection, disease, and transmission. In this paper we
show that a widely used H5N2 vaccine strain that has a HA1 protein
homology of 84% with the H5N1 challenge virus not only prevented
severe morbidity and mortality but also signiﬁcantly reduced virus
excretion and transmission of H5N1 in ducks two weeks after
vaccination.
Viruses and vaccines can be compared based on protein sequences
of the HA1. It should be kept in mind, however, that although there is a
correlation between genetic and antigenic distance, it is also possible
that speciﬁc genetic differences of only one amino acid lead to a
substantial difference in antigenic distance (Smith et al., 2004). For
inﬂuenza it has been observed that antigenic distance is linearly
related to the logarithm of the HI measurement. This principle is the
basis for the construction of antigenic maps in which antigenic
distances are visualized (Smith et al., 2004). In our study the low level
of genetic homology between virus and vaccine is conﬁrmed
antigenically in the HI assay. Fig. 2 shows that with the use of the
H5N2 antigen in the HI test titers are substantially higher than if it is
carried out with the H5N1 challenge antigen.
Although there is a clear relation between HI titers and antigenic
distance it is difﬁcult to relate antigenic distance to the level of
protection and reduction of transmission. We ﬁnd a substantial
difference (3.5 twofold dilutions) in the HI assay between the H5N1
and the H5N2 viruses, but the vaccine is still able to reduce
transmission and virus excretion and to protect the birds against
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updated when there is an antigenic difference of at least 2 twofold
dilutions in the HI assay (Smith et al., 2004). It would be a challenge to
develop corresponding criteria for avian vaccines. However it should
be borne in mind that there are various differences between avian and
human vaccination such as host differences, vaccination schedules,
and the use of different adjuvants.
The experimental set up could potentially inﬂuence the outcome of
transmission experiments. One of the factors that are of importance is
the moment of adding the contact birds to the inoculated birds. In our
experiments contact ducks were added at 1 day after inoculation
while in previous studies, where no transmission was found, the
contact animals were added at day 3 after inoculation (Webster et al.,
2006a; Beato et al., 2007). Since the dynamics of avian inﬂuenza virus
transmission in birds occur on a fast time scale of a few days (Van der
Goot et al., 2003, 2005, 2007), it is important that the contact birds are
added quickly after inoculation. Tables 1–4 indicate that the infectious
periods of the inoculated birds are short (1–5 days). Hence, if the
contact birds are added late, this may result in an underestimation of
the overall transmission level.
Two ducks in our experiments remained negative in both HI
tests and in the Np-antibody ELISA after vaccination, which makes
the fraction of non responders in our experiments 0.034 (95% CI:
0–0.08). Both ducks were infected, shed virus and seroconverted in
the experiments. One of these birds suffered from conjunctivitis
while the other showed no symptoms. These facts may seem of little
importance but if the reproduction ratio in unvaccinated birds is
high enough, even a low fraction of non responders may turn
attempts to prevent outbreaks by vaccination futile. For instance,
epidemiological theory states that the critical fraction of the
population that needs to be immune to obtain herd immunity, pc,
is related to the reproduction ratio R of an unvaccinated population
through: pc=1−1/R. Our point estimate of the reproduction ratio of
the unvaccinated group is 20. This implies that at least 95% of the
ducks should be fully protected by vaccination to obtain herd
immunity. This may be difﬁcult to achieve in an experimental
setting, let alone under ﬁeld conditions.
Overall, our results demonstrate that a widely used H5N2 vaccine
strain with a low level of genetic and antigenic homology with the
H5N1 challenge virus is able to reduce transmission in ducks
signiﬁcantly. Whether this is true in general remains to be
investigated, and therefore it is important to explore the effectiveness
of avian vaccines related to their genetic and antigenic distance to
circulating ﬁeld viruses.
Materials and methods
Ducks
Pekin ducks (Anas platyrhynchos) obtained from a duck farm were
used in all experiments. The ducks were tested in the ELISA to detect
antibodies against inﬂuenza prior to the experiments, and all were
negative. An overview of the ages of the ducks is given in Table 6. TheTable 6
Overview of the experiments
Treatment groupsa Age at vaccination Age at challenge
Unvaccinated na 8 weeks
Single vaccination, one weekb 7 weeks 8 weeks
Single vaccination, two weeksc 6 weeks 8 weeks
Double vaccination, two weeksd 6 and 9 weeks 11 weeks
na, vaccination was not applied.
a Every treatment group consisted of two groups of 10 ducks.
b Challenge one week after vaccination.
c Challenge two weeks after vaccination.
d Challenge two weeks after the second vaccination.experimentswere undertaken in a high containment unit under BSL3+
conditions at the Central Veterinary Institute of Wageningen UR. The
experiments comply with the Dutch law on animal experiments and
were reviewed by an ethical committee.
Virus and vaccine
The virus used in this study was A/Chicken/China/1204/04 H5N1.
The virus was obtained from the Veterinary Laboratories Agency in
Weybridge, is deposited in GenBank (accession number CAJ75442),
and belongs to clade 2.4. The virus is also known under the name: A/
Chicken/GxLA/1204/04, but since this is not a standard designationwe
did not use this name. For the transmission experiments ducks were
inoculated both intranasally and intratracheally with 0.1 ml diluted
allantoic ﬂuid containing 106.0 (experiments with a single vaccination)
or 106.5 (experiments with a double vaccination) median egg-
infectious dose (EID50) virus per ml. The inoculation dose per duck
was 105.3 and 105.8 EID50 respectively.
An inactivated oil emulsion vaccinewas used based on the strain A/
Chicken/Mexico/232/94/CPA H5N2 (Intervet Schering-Plough Animal
Health, The Netherlands). The vaccine is commercially available, and
widely used. A dosage of 0.5 ml vaccine was injected subcutaneously
in the lower part of the neck, as recommended by the manufacturer.
The protein homology of the genetically most variable region of the
hemagglutinin (HA1) between the vaccine strain and the challenge
strain is 84%.
Virus isolation
Swabs were put in 2 ml 2.95% tryptose phosphate buffer with
5×103 IU of penicillin-sodium and 5 mg streptomycin per ml. The
swabs were stored at −70 °C until analyzed. Three embryonated
chicken eggs (ECEs) incubated for 9 days were injected with 0.2 ml
of the swab ﬂuid per egg. After three days the allantoic ﬂuid was
harvested and a standard hemagglutination assay (HA) with chicken
red blood cells was performed (OIE, 2008a). When at least one of
the eggs was positive in the HA the swab was considered to be
positive.
RNA extraction and real time RT-PCR
Viral RNA was extracted using the MagNA Pure LC Total Nucleic
Acid Isolation Kit and the MagNA Pure LC Instrument (Roche®). Fluid
from the swabs (200 μl) was mixed with 300 μl lysis buffer. The rest of
the procedure was followed as recommended by the manufacturer.
Five μl of the extracted RNA was used in the RRT-PCR.
A one-tube RRT-PCR was performed to detect the matrix gene of
the inﬂuenza virus. The Qiagen one-step RT-PCR kit was used with a
25 μl reactionmixture containing 1 μl of kit-supplied enzymemixture,
1 μl dNTP mix, 4 U of RNase inhibitor (Promega, Madison, WI), 0.5 μM
of each primer M-Fw (5′-CTTCTAACCGAGGTCGAAACGTA-3′), M-Rev
(5′-CACTGGGCACGGTGAGC-3′), and 0.3 μM of probe M (5′-FAM-
CTCAAAGCCGAGATCGCGCAGA-3′-TAMRA). The RRT-PCR was per-
formed with the MX4000 (Stratagene®, Texas). The RT-PCR program
consisted of 30 min at 50 °C and 15 min at 95 °C. A three-step cycling
protocol was used as follows: 95 °C for 5 s, 58 °C for 15 s, and of 72 °C
for 20 s for 45 cycles.
Logistic regression
The relation between virus isolation (y) and the RRT-PCR (x) was
modeled by logistic regression:
log
P y ¼ þð Þ
1−P y ¼ þð Þ
 
¼ aþ bT x−1
44
96 J.A. van der Goot et al. / Virology 382 (2008) 91–97Here, x=1 was the lowest and x=45 was the highest Ct value (for
technical reasons a negative RRT-PCR result was given a Ct value of
45). The intercept a is associated with the highest probability for
positive virus isolation (for Ct value x=1), and (a+b) is associated with
the lowest probability for positive virus isolation (for Ct value x=45).
The logistic regression model was ﬁtted with the statistical program-
ming language GenStat (2007).
Antibody assays
The sera were incubated for 30 min at 56 °C, and subsequently
incubated with 20% chicken erythrocytes at 4 °C overnight. The
hemagglutination inhibition assay was performed by standard
methods (2008a). Brieﬂy, the test was performed in V-bottom 96
well microtiter plates with 8 hemagglutinating units of the H5N1
challenge virus or the H5N2 vaccine virus and 1% v/v speciﬁc-
pathogen-free chicken erythrocytes. A competitive ELISA that detects
antibodies against the nucleoprotein of inﬂuenza A was performed,
based on the ELISA that has been described before (De Boer et al.,1990).
Transmission experiments and quantiﬁcation of transmission
An overview of the experiments is given in Table 6. Within every
experimental group all ducks were given the same treatment, and all
experiments were performed in duplicate. The design of the
experiments is as follows: ﬁve ducks are inoculated with A/Chicken/
China/1204/04 H5N1 HPAI virus, and 24 h later these ﬁve ducks are
housed together with 5 uninfected contact birds. To monitor the
infection chain tracheal and cloacal swabs are taken daily during the
ﬁrst ten days and twice a week for the next 11 days. The experiments
were terminated 21 days after challenge.
The statistical analyses are based on a stochastic SEIR epidemic
model in which individuals are susceptible (S), latently infected (i.e.
infected but not yet infectious) (E), infected and infectious (I), and
recovered and immune or dead (R) (Anderson and May, 1991). The
aim is to obtain estimates of the basic reproduction ratio (R), as well
as the infectious period and the transmission rate parameter (β).
Here we rely on a ﬁnal size method and a Generalized Linear Model
(GLM). Technical details can be found in previous papers (Becker,
1989; De Jong and Kimman, 1994; Van der Goot et al., 2003, 2005,
2007; Velthuis et al., 2007). The analyses are based on the results of
the virus isolation in ECEs. For the ﬁnal size method we took an
exponentially distributed infectious period. For the GLM we have
assumed a latent period of 1 day, and the infectious periods are
directly observed from the infected contact birds. The analyses
were carried out in Mathematica 6.0 (ﬁnal size analysis) and SPSS
15.0 (GLM).
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